1. Home
  2. VTSI vs CELU Comparison

VTSI vs CELU Comparison

Compare VTSI & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

N/A

Current Price

$4.24

Market Cap

53.2M

ML Signal

N/A

Logo Celularity Inc.

CELU

Celularity Inc.

N/A

Current Price

$1.31

Market Cap

40.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VTSI
CELU
Founded
1993
2016
Country
United States
United States
Employees
N/A
123
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.2M
40.1M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
VTSI
CELU
Price
$4.24
$1.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$7.00
$6.00
AVG Volume (30 Days)
28.7K
80.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$16,524,225.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.39
$76.00
P/E Ratio
$46.78
N/A
Revenue Growth
5.57
N/A
52 Week Low
$3.57
$1.01
52 Week High
$7.47
$4.35

Technical Indicators

Market Signals
Indicator
VTSI
CELU
Relative Strength Index (RSI) 41.70 54.87
Support Level N/A $1.21
Resistance Level $5.15 $1.51
Average True Range (ATR) 0.19 0.12
MACD 0.01 0.01
Stochastic Oscillator 23.67 72.21

Price Performance

Historical Comparison
VTSI
CELU

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: